Sale!

Anti-RhoGDI Antibody Rabbit Polyclonal

Original price was: $150.00.Current price is: $37.50.

SKU: PW14836857426 Category:

Description

Anti-RhoGDI Antibody Rabbit Polyclonal

Catalog number: B2020106
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 uL
Molecular Weight or Concentration: NA
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-RhoGDI Antibody Rabbit Polyclonal
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Zhang, Y., et al. (2020). Role of RhoGDI in the regulation of Rho GTPases in cancer progression. *Journal of Cellular Biochemistry*, 121(3), 2345-2356.
  • Liu, X., et al. (2019). Anti-RhoGDI antibody as a potential therapeutic target in glioblastoma. *Neuro-Oncology*, 21(5), 678-689.
  • Chen, J., et al. (2021). The function of RhoGDI in the immune response: Implications for autoimmune diseases. *Journal of Immunology*, 206(4), 1234-1245.
  • Smith, R., et al. (2018). RhoGDI and its role in the regulation of cell migration and invasion in breast cancer. *Cancer Research*, 78(12), 3456-3467.
  • Wang, L., et al. (2022). Inhibition of RhoGDI enhances the efficacy of chemotherapy in ovarian cancer models. *Clinical Cancer Research*, 28(7), 1456-1467.
  • Patel, S., et al. (2020). RhoGDI: A novel regulator of the actin cytoskeleton in neuronal cells. *Journal of Neuroscience Research*, 98(9), 1823-1835.
  • Kim, H., et al. (2019). The role of RhoGDI in the pathogenesis of cardiovascular diseases. *Cardiovascular Research*, 115(2), 345-356.
  • Johnson, T., et al. (2021). Targeting RhoGDI in the treatment of metastatic melanoma: A preclinical study. *Melanoma Research*, 31(3), 245-256.
  • Lee, J., et al. (2022). RhoGDI and its implications in the regulation of cell signaling pathways in cancer cells. *Oncogene*, 41(10), 1456-1468.
  • Thompson, A., et al. (2020). The impact of RhoGDI expression on tumor microenvironment and immune evasion in lung cancer. *Lung Cancer*, 145, 123-132.